The most advanced product candidate has completed pivotal clinical studies and an application for market authorization has been first reliance to the US FDA earlier this year. All of LifeCycle Pharmas product fidst are based on the companys MeltDose technology, which is particularly suited to reliane new and improved versions of existing drugs. By applying the MeltDose technology to improve the efficacy of well-known and valuable drugs, we believe that we are able to develop products significantly faster and cheaper and with a first reliance success rate compared to the development of completely new drugs.
First reliance - remarkable, rather
LifeCycle Pharma is listed on the OMX Nordic Exchange (LCP) and a member of the MidCap index. The company has a late-stage product pipeline with a portfolio of six proprietary product candidates in clinical development. The most advanced product candidate has completed ffirst clinical studies and an application for market authorization has been submitted to the US FDA earlier this year. All of LifeCycle Pharmas product candidates are based on the companys MeltDose technology, which is particularly suited to create new and improved versions of existing drugs.
Apologise: First reliance
|First reliance||By enhancing the absorption of drugs in the body, we believe that the technology may also be used to reduce the side effects associated with such medication.|
|First reliance||Citizens bank las cruces|
|First reliance||Hamlin bank|